DURECT CORP
DRRXHealthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | |
|---|---|---|---|---|---|---|
| Revenue | $2.0M | $2.6M | $19.3M | $14.0M | $30.1M | $25.1M |
| Operating income | −$18.9M | −$39.7M | −$35.1M | −$34.3M | −$12.6M | −$19.9M |
| Net income | −$8.3M | −$27.6M | −$35.3M | −$36.3M | −$582,000 | −$20.6M |
| Total assets | $18.3M | $45.2M | $60.1M | $92.0M | $75.6M | $86.0M |
| Total liabilities | — | — | — | — | — | — |
| Equity | $9.1M | $14.8M | $25.0M | $57.8M | $40.1M | $22.9M |
| EPS (diluted) | $-0.27 | $-1.20 | $-1.55 | $-0.16 | $0.00 | $-0.12 |
| Shares out. | 31.0M | 24.5M | 227.7M | 227.2M | 195.8M | 162.1M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2024- Operating margin
- −931.2%
- Net margin
- −409.8%
- Return on equity
- −91.2%
- Return on assets
- −45.4%
- Return on capital (ROCE)
- −177.8%
- Liabilities / assets
- —
- Debt / equity
- —
- Book value / share
- $0.29
- Revenue growth (YoY)
- −21.6%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2024- Accruals / assets
- 58.7%high accruals
- Piotroski F-Score
- 4/8mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 5 warning● 0 good- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- Negative operating cash flow
- High accruals — earnings-quality risk
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Ingalls & Snyder LlcPassive (13G)Feb 21, 2025
- Asen R ScottPassive (13G)Jan 8, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| Aug 29, 2025 | 344,959 | 1.0 | -19.5% |
| Aug 15, 2025 | 428,609 | 1.0 | +6.9% |
| Jul 31, 2025 | 400,921 | 1.0 | -47.6% |
| Jul 15, 2025 | 764,814 | 15.0 | -2.9% |
| Jun 30, 2025 | 787,262 | 17.0 | -2.1% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventSep 11, 2025
- Results of operationsAug 12, 2025
- Entered a material agreementAug 8, 2025
- Entered a material agreement · Director / officer change · Regulation FD disclosureJul 29, 2025
- Delisting / listing-standard noticeJul 11, 2025
- Results of operationsMay 13, 2025
- Results of operationsMar 26, 2025
- Director / officer changeFeb 21, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.